What proportion of patients with heart failure are candidates for sacubitril/valsartan? Differences between guideline recommendations and regulatory labelsA. L. Clark,S. Bruce Wirta, M. Zhou,S. Kazmi,K. M. Goode,P. Pellicori, S. Corda, B. Balas,F. Calado,J. G. F. ClelandEuropean Heart Journal（2018）引用 0|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
